Biotech

All Articles

8 months after a $213M fundraise, gene editor Volume helps make reduces

.After raising $213 million in 2023-- among the year's most extensive private biotech shots-- Tome B...

BioMarin creates exec staff along with biotech veterinarians-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our summary of notable leadership hirings, shootings and re...

Biopharma Q2 VC attacked highest degree considering that '22, while M&ampA slowed

.Equity capital financing in to biopharma rose to $9.2 billion all over 215 sell the 2nd fourth of t...

Bicara, Zenas find IPOs to push late-phase properties toward market

.Bicara Therapeutics and also Zenas Biopharma have actually provided fresh impetus to the IPO market...

Genentech to close cancer cells immunology research study department

.Genentech will close its cancer cells immunology research study division, and unit head and disting...

Kezar drops solid growth yet to verify its truly worth in period 1 test

.Kezar Life Sciences is falling its dim phase 1 sound cyst medication as the biotech goes all-in on ...

Acelyrin falls izokibep, lays off 3rd of personnel

.Regardless of izokibep maintaining its own newly found winning touch in the center, Acelyrin is act...

Rivus' stage 2 obesity-related heart failure trial hits endpoint

.Rivus Pharmaceuticals has plumped up the customers of its own fat-busting, muscle-sparing medicatio...

Ovid standstills preclinical work, IV plan after soticlestat stop working

.Ovid Therapy currently exposed final month that it was actually trimming back its own headcount as ...

Eli Lilly opens $700M nucleic acid R&ampD center in Boston Port

.Eli Lilly has actually opened up a $700 thousand R&ampD facility in the Boston Port, improving its ...